Breaking News
Get 45% Off 0
🚨 Don’t miss your updated list of AI-picked stocks for this month
Pick Stocks with AI

CME Group (CME) Poised For Earnings Growth: Time To Buy?

By Zacks Investment ResearchStock MarketsAug 09, 2016 09:58PM ET
www.investing.com/analysis/cme-group-(cme)-poised-for-earnings-growth:-time-to-buy-200147185
CME Group (CME) Poised For Earnings Growth: Time To Buy?
By Zacks Investment Research   |  Aug 09, 2016 09:58PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
LCc1
-0.84%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CME
+1.57%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ARGO
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MKTX
+0.75%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AWHHF
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

On Aug 9, 2016, Zacks Investment Research upgraded CME Group Inc. (NASDAQ:CME) to Zacks Rank #2 (Buy).

Why the Upgrade?

CME Group has been witnessing a rise in earnings estimates on the back of strong second-quarter 2016 results. This securities exchange reported earnings of $1.14 that surpassed the Zacks Consensus Estimate by 2.7%. Earnings improved 15.2% year over year on record average daily volumes.

In the second quarter, the company witnessed a rise in contract volumes across geographies. In Europe, volumes in five of the company’s product areas surged more than 20%, with the strongest growth in energy and equities. In Asia, energy and metal volumes soared more than 140% and 80%, respectively. Latin America also demonstrated growth on the back of higher energy volumes.

CME Group witnessed solid revenue growth as well as cost-control induced margin expansion and earnings improvement in the second quarter. Four out of the company’s six product lines registered more than 20% year-over-year increase in volume and transaction fee revenues. CME Group reported revenue growth of 11% in the second quarter.

Additionally, its open interest reached an all-time high of more than 116 million contracts. This reflects an increased reliance of market participants on CME Group.

During the second quarter, CME Group became the first exchange to offer swaptions clearing that will enable clients to obtain the greater operational and capital efficiencies from clearing. This is expected to help the company develop more specialized products going forward. Recently, the company also progressed with its initiatives to enhance Live Cattle futures markets with feedback from the cattle industry.

The Zacks Consensus Estimate for 2016 moved up 2.8% to $4.47 per share as 88% of the estimates were revised higher over the last 30 days. For 2017, 88% estimates were revised higher over the same time frame, which raised the Zacks Consensus Estimate by 2.8% to $4.82 per share.

CME Group is well positioned for growth supported by its diverse derivative product lines. Also, the launch of products and effective capital deployment strengthen the company. In addition, its increasing global presence and meaningful acquisitions raise optimism. The long-term earnings growth is pegged at 9.7%.

CME GROUP INC Price and Consensus

CME GROUP INC Price and Consensus | CME GROUP INC Quote

Stocks to Consider

Investors interested in the finance sector can look for MarketAxess Holdings Inc. (NASDAQ:MKTX) , Allied World Assurance Company Holdings, AG (NYSE:AWH) and Argo Group International Holdings, Ltd. (NASDAQ:AGII) . All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7Best Stocks for the Next 30 Days. Click to get this free report >>



ARGO GROUP INTL (AGII): Free Stock Analysis Report

ALLIED WORLD AS (AWH): Free Stock Analysis Report

CME GROUP INC (CME): Free Stock Analysis Report

MARKETAXESS HLD (MKTX): Free Stock Analysis Report

Original post

CME Group (CME) Poised For Earnings Growth: Time To Buy?
 

Related Articles

CME Group (CME) Poised For Earnings Growth: Time To Buy?

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email